Tacrolimus ointment for the treatment of atopic dermatitis

Boucher M
Record ID 32001000957
English, French
Authors' objectives:

To summarise the available evidence on the use of tacrolimus ointment for the treatment of atopic dermatitis.

Authors' recomendations: - Atopic dermatitis (AD) is a chronic dermatological condition characterized by pruritus (itchiness) and rash. Topical corticosteroids are the mainstay of pharmacotherapy. - Tacrolimus ointment is a new topical anti-inflammatory agent available in Canada through the Special Access Program. - It is approved as a second line agent for short or long term intermittent treatment of moderate to severe AD. - Clinical trials suggest it is both effective and safe, but comparative studies with corticosteroids and long-term information are limited.
Authors' methods: Overview
Project Status: Completed
Year Published: 2001
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Anti-Inflammatory Agents
  • Dermatitis, Atopic
  • Eczema
Organisation Name: Canadian Coordinating Office for Health Technology Assessment
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553, Fax: +1 613 226 5392;
Contact Name: requests@cadth.ca
Contact Email: requests@cadth.ca
Copyright: Canadian Coordinating Office for Health Technology Assessment
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.